Sproul Ashley, Newman Hillary
, BScPharm, PharmD, is with Horizon Health Network, Saint John, New Brunswick.
, BScPharm, BScBio, is with Horizon Health Network, Saint John, New Brunswick.
Can J Hosp Pharm. 2023 Jul 5;76(3):185-195. doi: 10.4212/cjhp.3286. eCollection 2023 Summer.
Smart pump technology is relatively new, and uncertainty exists regarding best practices for development and management of the drug libraries in these devices. In Canadian hospitals, IV smart pumps and their drug libraries are created and maintained according to recommendations from Accreditation Canada and guidelines from the US Institute for Safe Medication Practices (ISMP). Current compliance with these standards in Canada is unknown. However, neither organization provides specific operational steps detailing how to effectively create and manage a drug library, which leaves significant room for interpretation. Furthermore, the human resources dedicated to creation and management of these libraries in accordance with guidelines and standards are unknown.
To describe current compliance with standards and guidelines for smart pump drug libraries; the processes used for drug library set-up, management, training, and support; and the resources currently used for these activities in Canadian hospitals.
A 43-question online survey was made available in spring 2021 to multidisciplinary team members involved in implementation of IV smart pumps and/or management of drug libraries in Canadian hospitals.
A total of 55 complete or partial responses were received. Most responses indicated that standards set by Accreditation Canada and ISMP were not being met, with only 30% (14/47) updating their libraries at least quarterly and 47% (20/43) performing quality reviews at least every 6 months. Although the majority of respondents reported regular monitoring of compliance, 30% (11/37) did not perform such monitoring. Results further indicated variation across Canadian hospitals in set-up, management, training, and support related to drug libraries, as well as variation in the human resources available for these activities.
Canadian health authorities and organizations are not meeting current ISMP and Accreditation Canada standards for smart pumps. Variation exists in terms of strategies for creating and managing drug libraries, as well as in the training and resources needed to support these initiatives. Canadian health authorities and organizations should prioritize meeting these standards and should closely review the resources required to do so.
智能泵技术相对较新,在这些设备中药物库的开发和管理的最佳实践方面存在不确定性。在加拿大医院,静脉输液智能泵及其药物库是根据加拿大认证协会的建议和美国安全用药实践研究所(ISMP)的指南创建和维护的。目前加拿大对这些标准的遵守情况尚不清楚。然而,这两个组织都没有提供详细说明如何有效创建和管理药物库的具体操作步骤,这留下了很大的解释空间。此外,按照指南和标准专门用于创建和管理这些库的人力资源情况也不清楚。
描述加拿大医院目前对智能泵药物库标准和指南的遵守情况;药物库设置、管理、培训和支持所使用的流程;以及目前用于这些活动的资源。
2021年春季,面向参与加拿大医院静脉输液智能泵实施和/或药物库管理的多学科团队成员开展了一项包含43个问题的在线调查。
共收到55份完整或部分回复。大多数回复表明未达到加拿大认证协会和ISMP制定的标准,只有30%(14/47)至少每季度更新一次药物库,47%(20/43)至少每6个月进行一次质量审查。尽管大多数受访者报告定期监测合规情况,但30%(11/37)未进行此类监测。结果还表明,加拿大各医院在药物库的设置、管理、培训和支持方面存在差异,以及开展这些活动可用的人力资源也存在差异。
加拿大卫生当局和组织未达到当前ISMP和加拿大认证协会关于智能泵的标准。在创建和管理药物库的策略以及支持这些举措所需的培训和资源方面存在差异。加拿大卫生当局和组织应优先满足这些标准,并应密切审查所需资源。